Protalix investing
WebbProtalix has partnered with Pfizer for worldwide development and commercialization of ELELYSO, excluding Israel, where Protalix has retained full rights. ... Protalix BioTherapeutics has 11 investors including Cybele Holdings and … WebbProtalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx ® plant cell-based expression system …
Protalix investing
Did you know?
Webb22 dec. 2024 · Dec 22, 2024, 06:50 ET. CARMIEL, Israel, Dec. 22, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development ... WebbDenna sida presenterar resultaträkningen (vinst- och förlusträkning) för Protalix Biotherapeutics Inc. Hitta bolagets finansiella resultat, intäkter och mycket mer.
WebbFå omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Protalix Biotherapeutics Inc aktien. Webb27 feb. 2024 · Get the latest Protalix earnings report, revenues and EPS as well as upcoming PLX earnings dates.
WebbProvides Protalix Biotherapeutics (PLX) main business data and analysis, including the revenue, costs, and profits of the past years and the latest release. You can query by quarterly, interim, and annual reports。 WebbFå detaljerad information om utdelningsdatum och utdelningsmeddelanden för Protalix.
Webb27 feb. 2024 · Investing.com - Protalix (NYSE: PLX) reported fourth quarter EPS of $-0.220, $0.07 worse than the analyst estimate of $-0.150. Revenue for the quarter came in at $62.89M versus the consensus...
WebbAlla relevanta kommentarer och diskussioner sammanställda om PLX Aktien. is slyg a good investmentWebb21 dec. 2024 · Protalix BioTherapeutics, Inc. Dec 21, 2024, 16:30 ET. The Company's Common Stock will continue to trade on the NYSE American. CARMIEL, Israel, Dec. 21, 2024 /PRNewswire/ -- Protalix ... is sly cooper on xboxWebb21 mars 2024 · This table contains core financial ratios such as Price-to-Earnings , Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Protalix Biotherapeutics Inc's latest ... if contains any text excelWebbProtalix Biotherapeutics stock was originally listed at a price of $850.00 in May 15, 1998. If you had invested in Protalix Biotherapeutics stock at $850.00, your return over the last 24 years would have been -99.75%, for an annualized return of -22.13% (not including any dividends or dividend reinvestments). if contains a string excelWebb11 okt. 2024 · Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. is sly cooper on nintendo switchWebbPLX Smart Score - Investing.com Protalix Biotherapeutics Inc (PLX) NYSE Create Alert Add to Watchlist 2.240 +0.030 +1.36% 09:48:35 - Real-time Cboe. Currency in USD ( Disclaimer ) Type: Equity... if contains a word excel formulaWebb11 apr. 2024 · Protalix BioTherapeutics (NYSE:PLX) has a market capitalization of $126.75 million and generates $47.64 million in revenue each year. The company earns $-14,930,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis. if contains in excel